Developer docs
API playgroundTry for free, no card

Search company profiles

Phynova Group

Full company profile

uuid0003hu2

Namestring
Phynova Group
Legal namestring
Phynova Group Ltd.
Websiteurl
phynova.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Phynova Group Ltd is a privately held British life science company, founded in Oxford in 2002, that develops and commercialises natural health ingredients derived from plants with traditional medicine histories. The company operates an R&D platform that converts botanicals — particularly with provenance in traditional Chinese medicine — into novel, science-validated, IP-protected ingredients, supported by a wholly-owned research subsidiary in Beijing, China.

The company's flagship asset is Reducose®, a patented water extract of white mulberry leaves (marketed at 5% concentration) that competitively inhibits alpha-glucosidase enzymes in the small intestine, preventing carbohydrate breakdown for approximately one hour, and is then absorbed and excreted unmetabolized without disrupting the gut microbiome. Reducose® is supported by nine published human clinical trials and is reported to reduce post-meal blood glucose by up to 40%, with additional effects on insulin response, satiety, and second-meal glucose. The company has also developed a microencapsulation technology under Innovate UK grant funding to reduce flavour and texture impact for food and beverage applications.

Phynova monetises Reducose® through a B2B ingredient licensing and sales model, primarily routed via four exclusive regional distribution partners — Bioriginal (North America), Membra (Malaysia), InVita-Trade (Russia/CIS), and Ingredients Plus (Oceania) — and through direct strategic partnerships with consumer brand customers including Nestlé Health Science (Nutren GlucoSmart in South East Asia) and Sugarbreak (Kids' Collection in 1,800 Target stores in the US). Revenue is generated from ingredient sales, turn-key formulation services, and licensing; product pricing is quote-based and not publicly disclosed. The company has 11–50 employees and is registered in England and Wales.

Short descriptiontext

Phynova Group is a British life science company, founded in 2002, that develops and commercialises patented natural health ingredients — led by the mulberry-leaf extract Reducose® — and sells them B2B to food, beverage, and supplement brands across global markets via regional distribution partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBanbury, United Kingdom
HQ citystring
Banbury
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
natural health ingredients, botanical extracts, functional food ingredients, blood glucose management, dietary supplement ingredients
Industry2 codes
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAGAD
Herbal & Botanical Supplements
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Food And Kindred Products2000
Product category
Nutraceutical Ingredients
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Ingredient Licensing and Sales
TypeLicensing Royalties
Description

Phynova licenses and sells its Reducose® ingredient to food and beverage manufacturers, supplement brands, and other companies for use in their products. Revenue is generated through ingredient sales and licensing agreements with B2B customers.

phynova.com
2Turn-key Solutions and Formulation Services
TypeProfessional Services
Description

Distribution partners like Bioriginal serve customers with Reducose® as a stand-alone ingredient or as a hero-ingredient in turn-key solutions, providing formulation support and ready-to-market concepts.

phynova.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Reducose
Description

Proprietary water extract of mulberry leaf for blood glucose management. Clinically researched ingredient that inhibits carbohydrate-digesting enzymes to reduce post-meal blood sugar and insulin spikes. Available in 5% concentration, vegetarian, plant-based, and allergen-free.

phynova.com
+1 more record
Core offering1 text field

Phynova Group develops and commercialises proprietary, science-validated natural health ingredients derived from plants with histories of use in traditional medicine. Its flagship product is Reducose®, a patented water extract of white mulberry leaves that competitively inhibits carbohydrate-digesting enzymes to reduce post-meal blood glucose and insulin response, sold as a B2B ingredient to food, beverage and supplement manufacturers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 40% reduction in post-meal blood glucose and insulin response
+5 more records
Product overview1 text field

Phynova is a British life science company that develops and commercializes science-proven health ingredients powered by plants. The company's primary product is Reducose®, a patented mulberry leaf extract for blood glucose management. Phynova also maintains a portfolio of functional ingredients, cosmeceuticals, pharmaceuticals, and OTC products based on traditional medicine principles. The company operates an R&D platform that converts plants with traditional use history into novel products validated by contemporary science and protected by intellectual property.

Product and service2 records
1Reducose®
CategoryFunctional Food Ingredient
Description

Reducose® is a proprietary water extract of white mulberry leaves that competitively inhibits alpha-glucosidase enzymes in the small intestine, preventing the breakdown of carbohydrates into glucose for approximately one hour. The ingredient is then absorbed and excreted unmetabolized without affecting the microbiome, reducing postprandial blood glucose and insulin response by up to 40%. Sold B2B to food, beverage and dietary supplement manufacturers for use in blood glucose management products.

2Chloe LiveLab
CategoryResearch Service Platform
Description

Chloe LiveLab is a collaborative research model co-developed with People Science that enables ingredient suppliers and consumer brands to run real-world evidence studies using continuous glucose monitors and the Chloe app. The first activation showcases Phynova's Reducose® ingredient and is intended to expand to additional functional ingredient categories, inviting other suppliers and brands to participate.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-04
Description

Launched Chloe LiveLab at SupplySide Global in Las Vegas, a collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. The first activation features Phynova's Reducose® for blood glucose management, with live demonstrations using continuous glucose monitors and the Chloe app.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-01
Description

Collaborative research partnership for clinical studies on Reducose®. Received Innovate UK grant as part of the 'Better Food for All' programme to investigate long-term benefits of Reducose® and microencapsulation technology. This is the third collaboration between Phynova and OxBCNH.

Strategic tierCoreTypeOthersAnnounced on2023-09-01
Description

Innovate UK, the UK Government Innovation agency, provided grant funding as part of the 'Better Food for All' programme to support research into Reducose® effectiveness in combating excess carbohydrate consumption from modern diets.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-06-01
Description

Distribution partnership for Reducose® for use in Supplement applications to customers in Oceania (Australia and New Zealand). Ingredients Plus is a leading independent distributor in the Asia-Pacific Region.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-01-01
Description

Exclusive distribution agreement for Reducose® for use in Food and Supplement applications to customers in Russia, Kazakhstan, Belarus, and Armenia. InVita is a health ingredients specialist distributor with over 20 years industry experience.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-10-27
Description

Nestlé Health Science launched Nutren GlucoSmart featuring Reducose® in Asia. The product contains clinically studied mulberry leaf extract for 40% reduction of post-prandial blood glucose response. Available as powdered sprinkle format.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-10-11
Description

Partnership for Malaysian market encompassing both distribution to Malaysian customers as well as joint promotion of Reducose® health benefits. Membra serves customers with Reducose® as stand-alone ingredient or as hero-ingredient in turn-key solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-09-01
Description

Partnership for North American market covering both distribution to customers and joint promotion of Reducose® health benefits. Bioriginal serves customers with Reducose® as standalone ingredient or as hero-ingredient in turn-key solutions.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-04-01
Description

Phynova is a scientific and business partner to Sugarbreak. Their product lines for both adults and children are powered by Phynova's Reducose®, with Kids' Collection available at 1,800 Target stores nationwide in the US.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sabinsa is one of the largest clinically-studied botanical extract suppliers, marketing branded ingredients (e.g., branded extracts for metabolic and joint health) to nutraceutical and functional food manufacturers globally. Closely comparable to Phynova's branded, IP-protected extract model.

2Naturex (Givaudan)
TypeBroad incumbent
Description

Naturex (now part of Givaudan's Taste & Wellbeing division) is a major global supplier of plant-based extracts and natural ingredients to food, beverage, and nutraceutical customers. Overlapping product categories with Phynova but vastly larger portfolio and geographic reach.

TypeBroad incumbent
Description

ADM Nutrition is a global agribusiness and ingredient supplier offering a broad range of plant-based functional ingredients to food, beverage, and supplement manufacturers. Substantial overlap on the B2B ingredient side but operates at dramatically greater scale across many product categories.

TypeDirect peer
Description

Gencor Pacific develops and licenses branded, clinically studied botanical and nutraceutical ingredients to global supplement and functional food manufacturers. Similar ingredient licensing/royalty revenue model and clinical-validation-led go-to-market as Phynova.

TypeBroad incumbent
Description

Kemin is a global ingredient manufacturer supplying branded plant-derived and specialty ingredients across human nutrition, animal nutrition, and personal care. Comparable ingredient B2B model but operates across multiple categories at much greater scale.

TypeDirect peer
Description

OmniActive supplies branded, clinically researched plant-derived ingredients (e.g., for metabolic, eye, and joint health) to supplement and functional food brands. Comparable proprietary-extract, B2B-led business model.

TypeDirect peer
Description

Euromed produces standardized botanical extracts and fruit/vegetable-derived actives for nutraceutical and functional food brands. Closely comparable as a science-led, standardized botanical extract B2B supplier operating in similar end-markets to Phynova.

8Martin Bauer Group
TypeBroad incumbent
Description

Martin Bauer is a large, established botanical extract and functional ingredient supplier serving tea, beverage, food, and supplement industries globally. Comparable upstream technology platform but significantly broader scale and category footprint than Phynova.

TypeDirect peer
Description

Indena is an Italian botanical extract manufacturer supplying standardized, science-backed plant-derived ingredients to the nutraceutical, pharmaceutical, and functional food industries. Highly comparable technology, regulatory, and B2B GTM profile to Phynova.

TypeDirect peer
Description

NuLiv Science supplies branded, clinically researched nutraceutical ingredients including metabolic-health actives to global B2B customers. Direct overlap with Phynova's blood-glucose-management positioning and clinical-evidence-led sales motion.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phynova Group

Nutraceutical Ingredientsphynova.com

Phynova Group is a British life science company, founded in 2002, that develops and commercialises patented natural health ingredients — led by the mulberry-leaf extract Reducose® — and sells them B2B to food, beverage, and supplement brands across global markets via regional distribution partners.

What Phynova Group does

Phynova Group Ltd is a privately held British life science company, founded in Oxford in 2002, that develops and commercialises natural health ingredients derived from plants with traditional medicine histories. The company operates an R&D platform that converts botanicals — particularly with provenance in traditional Chinese medicine — into novel, science-validated, IP-protected ingredients, supported by a wholly-owned research subsidiary in Beijing, China.

The company's flagship asset is Reducose®, a patented water extract of white mulberry leaves (marketed at 5% concentration) that competitively inhibits alpha-glucosidase enzymes in the small intestine, preventing carbohydrate breakdown for approximately one hour, and is then absorbed and excreted unmetabolized without disrupting the gut microbiome. Reducose® is supported by nine published human clinical trials and is reported to reduce post-meal blood glucose by up to 40%, with additional effects on insulin response, satiety, and second-meal glucose. The company has also developed a microencapsulation technology under Innovate UK grant funding to reduce flavour and texture impact for food and beverage applications.

Phynova monetises Reducose® through a B2B ingredient licensing and sales model, primarily routed via four exclusive regional distribution partners — Bioriginal (North America), Membra (Malaysia), InVita-Trade (Russia/CIS), and Ingredients Plus (Oceania) — and through direct strategic partnerships with consumer brand customers including Nestlé Health Science (Nutren GlucoSmart in South East Asia) and Sugarbreak (Kids' Collection in 1,800 Target stores in the US). Revenue is generated from ingredient sales, turn-key formulation services, and licensing; product pricing is quote-based and not publicly disclosed. The company has 11–50 employees and is registered in England and Wales.

Phynova Group firmographics

Firmographics
Name
Phynova Group
Legal name
Phynova Group Ltd.
Website
https://phynova.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
Phynova Group is a British life science company, founded in 2002, that develops and commercialises patented natural health ingredients — led by the mulberry-leaf extract Reducose® — and sells them B2B to food, beverage, and supplement brands across global markets via regional distribution partners.
Ownership category
akta.pro rank

Phynova Group industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAGAD
Herbal & Botanical Supplements

Keywords

  • Natural health ingredients
  • Botanical extracts
  • Functional food ingredients
  • Blood glucose management
  • Dietary supplement ingredients

Where Phynova Group is headquartered

Location

Headquarters

HQ city
Banbury
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

Phynova Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel

Revenue model

  1. Ingredient Licensing and Sales: Phynova licenses and sells its Reducose® ingredient to food and beverage manufacturers, supplement brands, and other companies for use in their products. Revenue is generated through ingredient sales and licensing agreements with B2B customers.
  2. Turn-key Solutions and Formulation Services: Distribution partners like Bioriginal serve customers with Reducose® as a stand-alone ingredient or as a hero-ingredient in turn-key solutions, providing formulation support and ready-to-market concepts.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Phynova Group product offering

Product offering

Core offering

Phynova Group develops and commercialises proprietary, science-validated natural health ingredients derived from plants with histories of use in traditional medicine. Its flagship product is Reducose®, a patented water extract of white mulberry leaves that competitively inhibits carbohydrate-digesting enzymes to reduce post-meal blood glucose and insulin response, sold as a B2B ingredient to food, beverage and supplement manufacturers globally.

Product overview

Phynova is a British life science company that develops and commercializes science-proven health ingredients powered by plants. The company's primary product is Reducose®, a patented mulberry leaf extract for blood glucose management. Phynova also maintains a portfolio of functional ingredients, cosmeceuticals, pharmaceuticals, and OTC products based on traditional medicine principles. The company operates an R&D platform that converts plants with traditional use history into novel products validated by contemporary science and protected by intellectual property.

Differentiator

Problem solved

Functional benefit

Brands

  • Reducose: Proprietary water extract of mulberry leaf for blood glucose management. Clinically researched ingredient that inhibits carbohydrate-digesting enzymes to reduce post-meal blood sugar and insulin spikes. Available in 5% concentration, vegetarian, plant-based, and allergen-free.
  • Chloe LiveLab

Products and services

  • Reducose® Reducose® is a proprietary water extract of white mulberry leaves that competitively inhibits alpha-glucosidase enzymes in the small intestine, preventing the breakdown of carbohydrates into glucose for approximately one hour. The ingredient is then absorbed and excreted unmetabolized without affecting the microbiome, reducing postprandial blood glucose and insulin response by up to 40%. Sold B2B to food, beverage and dietary supplement manufacturers for use in blood glucose management products.
  • Chloe LiveLab Chloe LiveLab is a collaborative research model co-developed with People Science that enables ingredient suppliers and consumer brands to run real-world evidence studies using continuous glucose monitors and the Chloe app. The first activation showcases Phynova's Reducose® ingredient and is intended to expand to additional functional ingredient categories, inviting other suppliers and brands to participate.

Quantifiable outcome

  • 40% reduction in post-meal blood glucose and insulin response
  • +5 more outcomes

Companies that use Phynova Group

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Phynova Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Phynova Group partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and flagship.

  • People SciencecoreStrategic or Co-development Partner · 4 November 2025Launched Chloe LiveLab at SupplySide Global in Las Vegas, a collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. The first activation features Phynova's Reducose® for blood glucose management, with live demonstrations using continuous glucose monitors and the Chloe app.
  • Oxford Brookes Centre for Nutrition and HealthcoreStrategic or Co-development Partner · 1 September 2023Collaborative research partnership for clinical studies on Reducose®. Received Innovate UK grant as part of the 'Better Food for All' programme to investigate long-term benefits of Reducose® and microencapsulation technology. This is the third collaboration between Phynova and OxBCNH.
  • Innovate UKcoreOthers · 1 September 2023Innovate UK, the UK Government Innovation agency, provided grant funding as part of the 'Better Food for All' programme to support research into Reducose® effectiveness in combating excess carbohydrate consumption from modern diets.
  • Ingredients PluscoreChannel Partner/ Reseller/ Distributor · 1 June 2022Distribution partnership for Reducose® for use in Supplement applications to customers in Oceania (Australia and New Zealand). Ingredients Plus is a leading independent distributor in the Asia-Pacific Region.
  • INVITA-TradecoreChannel Partner/ Reseller/ Distributor · 1 January 2022Exclusive distribution agreement for Reducose® for use in Food and Supplement applications to customers in Russia, Kazakhstan, Belarus, and Armenia. InVita is a health ingredients specialist distributor with over 20 years industry experience.
  • Nestlé Health ScienceflagshipStrategic or Co-development Partner · 27 October 2021Nestlé Health Science launched Nutren GlucoSmart featuring Reducose® in Asia. The product contains clinically studied mulberry leaf extract for 40% reduction of post-prandial blood glucose response. Available as powdered sprinkle format.
  • Membrahealth Marketing (M) Sdn BhdcoreChannel Partner/ Reseller/ Distributor · 11 October 2021Partnership for Malaysian market encompassing both distribution to Malaysian customers as well as joint promotion of Reducose® health benefits. Membra serves customers with Reducose® as stand-alone ingredient or as hero-ingredient in turn-key solutions.
  • Bioriginal Food & Science CorpcoreChannel Partner/ Reseller/ Distributor · 1 September 2021Partnership for North American market covering both distribution to customers and joint promotion of Reducose® health benefits. Bioriginal serves customers with Reducose® as standalone ingredient or as hero-ingredient in turn-key solutions.
  • SugarbreakcoreOEM/ Whitelabel/ Licensing Partner · 1 April 2021Phynova is a scientific and business partner to Sugarbreak. Their product lines for both adults and children are powered by Phynova's Reducose®, with Kids' Collection available at 1,800 Target stores nationwide in the US.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Phynova Group competitors and assessment

Company assessment

Direct peers

  • Sabinsa Corporation: Sabinsa is one of the largest clinically-studied botanical extract suppliers, marketing branded ingredients (e.g., branded extracts for metabolic and joint health) to nutraceutical and functional food manufacturers globally. Closely comparable to Phynova's branded, IP-protected extract model.
  • Gencor Pacific: Gencor Pacific develops and licenses branded, clinically studied botanical and nutraceutical ingredients to global supplement and functional food manufacturers. Similar ingredient licensing/royalty revenue model and clinical-validation-led go-to-market as Phynova.
  • OmniActive Health Technologies: OmniActive supplies branded, clinically researched plant-derived ingredients (e.g., for metabolic, eye, and joint health) to supplement and functional food brands. Comparable proprietary-extract, B2B-led business model.
  • Euromed S.A. Euromed produces standardized botanical extracts and fruit/vegetable-derived actives for nutraceutical and functional food brands. Closely comparable as a science-led, standardized botanical extract B2B supplier operating in similar end-markets to Phynova.
  • Indena S.p.A. Indena is an Italian botanical extract manufacturer supplying standardized, science-backed plant-derived ingredients to the nutraceutical, pharmaceutical, and functional food industries. Highly comparable technology, regulatory, and B2B GTM profile to Phynova.
  • NuLiv Science: NuLiv Science supplies branded, clinically researched nutraceutical ingredients including metabolic-health actives to global B2B customers. Direct overlap with Phynova's blood-glucose-management positioning and clinical-evidence-led sales motion.

Broad incumbents

  • Naturex (Givaudan): Naturex (now part of Givaudan's Taste & Wellbeing division) is a major global supplier of plant-based extracts and natural ingredients to food, beverage, and nutraceutical customers. Overlapping product categories with Phynova but vastly larger portfolio and geographic reach.
  • ADM Nutrition: ADM Nutrition is a global agribusiness and ingredient supplier offering a broad range of plant-based functional ingredients to food, beverage, and supplement manufacturers. Substantial overlap on the B2B ingredient side but operates at dramatically greater scale across many product categories.
  • Kemin Industries: Kemin is a global ingredient manufacturer supplying branded plant-derived and specialty ingredients across human nutrition, animal nutrition, and personal care. Comparable ingredient B2B model but operates across multiple categories at much greater scale.
  • Martin Bauer Group: Martin Bauer is a large, established botanical extract and functional ingredient supplier serving tea, beverage, food, and supplement industries globally. Comparable upstream technology platform but significantly broader scale and category footprint than Phynova.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Phynova Group social profiles

Digital presence

Phynova Group compliance and trust

Trust signal

Compliance1 record

Phynova Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phynova Group leadership team

Management profile

Number of profiles

Profiles2 records

Phynova Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Phynova Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phynova Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phynova Group

What does Phynova Group do?

Phynova Group develops and commercialises proprietary, science-validated natural health ingredients derived from plants with histories of use in traditional medicine. Its flagship product is Reducose®, a patented water extract of white mulberry leaves that competitively inhibits carbohydrate-digesting enzymes to reduce post-meal blood glucose and insulin response, sold as a B2B ingredient to food, beverage and supplement manufacturers globally.

Is Phynova Group a public or private company?

Phynova Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Phynova Group founded?

Phynova Group was founded in 2002. It employs 11 to 50 people.

Where is Phynova Group based?

Phynova Group is headquartered in Banbury, United Kingdom, in the Europe region.

How does Phynova Group make money?

Two revenue lines are on record. Ingredient Licensing and Sales are the primary driver. The others are turn-key Solutions and Formulation Services.

Who are Phynova Group's main competitors?

Direct peers on record are Sabinsa Corporation, Gencor Pacific, OmniActive Health Technologies, Euromed S.A., Indena S.p.A. and NuLiv Science. Broad incumbents are Naturex (Givaudan), ADM Nutrition, Kemin Industries and Martin Bauer Group.

Does Phynova Group have an API?

No public API is recorded for Phynova Group.

What industry is Phynova Group in?

Phynova Group's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarPeople Science and Phynova Launch Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model to Generate Real-World EvidencePeople Science and Phynova launched Chloe LiveLab at SupplySide Global, a model for real-world evidence generation. The first activation featured Reducose with consumers wearing CGMs to visualize glucose responses. The company plans to expand the model into additional functional ingredient categories.PR NewswirePeople Science and Phynova Launch Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model to Generate Real-World EvidencePeople Science and Phynova launched Chloe LiveLab at SupplySide Global in Las Vegas on November 4, 2025, a new collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through open-label studies deployed via the Chloe platform and app. The first LiveLab activation features Reducose, Phynova's clinically researched natural ingredient for blood glucose management, with live demonstrations showing how consumer health brand leaders used continuous glucose monitors to visualize their own glucose responses. The platform converts validated randomized controlled trial designs into consumer-facing studies, providing data-driven support for brand partners while offering consumers immediate insight into product performance.Business Wire BlogFrom AI to Energy Optimization: Barilla and Plug and Play Recognize the Most Innovative Food-Tech StartupsBarilla and Plug and Play announced four winners of the 2024 Good Food Makers program: Voxpopme, Phynova, Ecop, and Manual.to. The startups will receive €40,000 and collaborate with Barilla, following the program's 2019 launch. Barilla also completed blockchain traceability for its pesto basil supply chain in 2024.